Mutagenicity and co-mutagenicity of static magnetic fields detected by bacterial mutation assay

Mutat Res. 1999 Jun 30;427(2):147-56. doi: 10.1016/s0027-5107(99)00087-1.

Abstract

Possible mutagenic and co-mutagenic effects of strong static magnetic fields were estimated using bacterial mutagenicity test. Mutagenic potential of static magnetic fields up to 5T (T:1T=10,000 G) was not detected by the bacterial mutagenicity test using four strains of Salmonella typhimurium (TA98, TA100, TA1535 and TA1537) and Escherichia coli WP2 uvrA either in the pre-incubation method or in the plate incorporation method. In the co-mutagenicity test, E. coli WP2 uvrA cells were treated with various chemical mutagens and were simultaneously exposed to a 2T or a 5T static magnetic field. Mutation rate in the exposed group was significantly higher than that in the non-exposed group when cells were treated with N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG), N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), ethylmethanesulfonate (EMS), 4-nitroquinoline-N-oxide (4-NQO), 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline (IQ) or 2-(2-furyl)-3-(5-nitro-2-furyl) acrylamide (AF-2). The mutagenicity of 2-aminoanthracene (2-AA), 9-aminoacridine (9-AA), N4-aminocytidine and 2-acetoamidofluorene (2-AAF) was not affected by the magnetic field exposure. Possible mechanisms of the co-mutagenicity of magnetic fields are discussed.

MeSH terms

  • Animals
  • Bacteria / genetics*
  • Cell Division
  • Escherichia coli / genetics
  • Liver / metabolism
  • Magnetics / adverse effects*
  • Methylnitronitrosoguanidine / analogs & derivatives
  • Methylnitronitrosoguanidine / pharmacology
  • Mutagenicity Tests*
  • Mutagens / pharmacology
  • Mutation
  • Rats
  • Salmonella typhimurium / genetics

Substances

  • Mutagens
  • Methylnitronitrosoguanidine
  • ENNG